Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Diclofenac diethylamine

SKU: orb1224009

Description

Diclofenac Diethylamine is a non-selective COX inhibitor used as a nonsteroidal anti-inflammatory drug (NSAID).(In Vitro):Diclofenac effectively blocks COX-1 mediated prostanoid production from U937 cell microsomes, with an IC50 of 7±3 nM.Diclofenac (1-60 μM; 1 day) induces neural stem cells (NSCs)death in a concentration-dependent manner.Diclofenac (10-60 μM; 6 hours) increases the expression of cleaved (activated) caspase-3.(In Vivo):Diclofenac (3 mg/kg, b.i.d., for 5 days) significantly increases faecal 51Cr excretion in rats, and such effect is also observed in squirrel monkeys after administrated of 1 mg/kg twice daily for 4 days.Diclofenac (10 mg/kg; administered via oral route just prior to induction of inflammation) shows in vivo anti-inflammatory activity in Wistar rats.

Research Area

Pharmacology & Drug Discovery

Images & Validation

Key Properties

CAS Number78213-16-8
MW369.29
Purity>98% (HPLC)
FormulaC18H22Cl2N2O2
SMILESCCNCC.OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl
TargetOthers
SolubilityEthanol: 74 mg/mL (200.38 mM); DMSO: 74 mg/mL (200.38 mM)

Bioactivity

In Vivo
Diclofenac (3 mg/kg, b. i. d. , for 5 days) significantly increases faecal 51Cr excretion in rats, and such effect is also observed in squirrel monkeys after administrated of 1 mg/kg twice daily for 4 days. Diclofenac (10 mg/kg; administered via oral route just prior to induction of inflammation) shows In vivo anti-inflammatory activity in Wistar rats. Animal model: Male Sprague-Dawley rats (150±200 g). Dosage: 3 mg/kg. Administration: Oral administration, b. i. d. , for 5 days. Result: Resulted in a significant increase in faecal 51Cr excretion. Animal model: Wistar rats (150-175 g) bearing Formalin-induced rat foot paw edema model. Dosage: 10 mg/kg. Administration: Administered via oral route just prior to induction of inflammation. Result: Showed In vivo anti-inflammatory activity (% edema inhibition = 29.2, 1 h; 22.2, 3 h; 20, 6 h).
In Vitro
Diclofenac effectively blocks COX-1 mediated prostanoid production from U937 cell microsomes, with an IC50 of 7±3 nM. Diclofenac (1-60 μM; 1 day) induces neural stem cells (NSCs)death in a concentration-dependent manner. Diclofenac (10-60 μM; 6 hours) increases the expression of cleaved (activated) caspase-3. Cell Viability Assay Cell line: Neural stem cells (NSCs). Concentration: 1, 3, 10, 30, 60 μM. Incubation time: 1 day. Result: Induction of cell death was concentration-dependent and the effect was not saturated at a concentration of up to 60 μM. Western blot analysis. Cell line: Neural stem cells (NSCs). Concentration: 10, 30 or 60 μM. Incubation time: 6 hours. Result: The activation of caspase-3 was increased in a concentration-dependent manner.

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

  • Diclofenac diethylamine [orb1310622]

    >99.99% (May vary between batches)

    78213-16-8

    369.29

    C18H22Cl2N2O2

    1 ml x 10 mM (in DMSO), 50 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Protocol Information

Available Sizes

Select a size below

100 mg
500 mg
200 mg
25 mg
$ 100.00
50 mg
$ 140.00